NCT04484246 Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy Status COMPLETED Phase N/A
NCT04484038 Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma Status UNKNOWN Phase NA
NCT04478279 A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04470843 Impact of Acetazolamide in Reducing Referred Postoperative Pain Status COMPLETED Phase PHASE1
NCT04465500 EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04465214 Mobile Sensor Technologies to Assess General Symptomology of People With Cancer Status COMPLETED Phase N/A
NCT04462926 Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed Status UNKNOWN Phase NA
NCT04457882 Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube Status UNKNOWN Phase NA
NCT04452136 Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer Status APPROVED_FOR_MARKETING Phase N/A
NCT04443062 Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer Status COMPLETED Phase PHASE2
NCT04441775 Artificial Intelligence for Prostate Cancer Treatment Planning Status COMPLETED Phase N/A
NCT04430842 Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S Status COMPLETED Phase PHASE1
NCT04428203 Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer Status COMPLETED Phase PHASE1
NCT04424654 Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy Status COMPLETED Phase PHASE2
NCT04424641 A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04423913 Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy Status TERMINATED Phase PHASE2
NCT04422132 Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks Status ACTIVE_NOT_RECRUITING Phase PHASE2